Acumen Pharmaceuticals

Acumen Pharmaceuticals (NASDAQ: ABOS)

This biopharmaceutical company develops monoclonal antibody therapies targeting toxic amyloid-beta oligomers for the treatment of patients with early-stage Alzheimer's disease.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Alzinova

This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.

Monument Biosciences

This biotechnology company develops disease-modifying drugs and translational biomarkers to treat Alzheimer's disease and related dementias.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.

Rodin Therapeutics

This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.